Sodium Ascorbate Inj 250mg/mL 250 mg Liquid is a Health Canada–registered veterinary drug (DIN 00611867) held by Dominion Veterinary Laboratories Ltd., containing Sodium Ascorbate. Health Canada lists its status as Dormant (status date 02 Oct 2020). Nexara Health has matched 23 registrations of Sodium Ascorbate across 3 other regulated markets.
Health Canada registration
| DIN | 00611867 |
|---|---|
| Brand name | Sodium Ascorbate Inj 250mg/mL |
| Active ingredient | Sodium Ascorbate |
| Strength | 250 mg |
| Dosage form | Liquid |
| Route | Intramuscular |
| Company | Dominion Veterinary Laboratories Ltd. |
| Status | Dormant — 02 Oct 2020 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Sodium Ascorbate registered in other markets
23 registrations of the same molecule in 3 national registries outside Canada (first 13 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Sodium Ascorbate | E.r. Squibb & Sons Inc. | （粉） | 已註銷 | TFDA | |
| Taiwan | Sodium Ascorbate | Takeda Pharmaceutical Company Limited (Hikari Plant) | （粉） | 已註銷 | TFDA | |
| Taiwan | Sodium Ascorbate | Cspc Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. | （粉） | Registered | TFDA | |
| Taiwan | Sodium Ascorbate | E.r. Squibb & Sons Inc. | （粉） | 已註銷 | TFDA | |
| Taiwan | Sodium Ascorbate | Eli. Lilly & Co. | （粉） | 已註銷 | TFDA | |
| Taiwan | Sodium Ascorbate "E.merck" | MERCK KGaA | （粉） | 已註銷 | TFDA | |
| Taiwan | Sodium Ascorbate (Vitamin C Sodium Salt) | Roche Vitamins Ltd. | （粉） | 已註銷 | TFDA | |
| Taiwan | Sodium Ascorbate Crystal | Takeda Chemical Industries Ltd.(Hikari Plant) | 原料藥結晶性粉末 | 已註銷 | TFDA | |
| United Kingdom | Sodium ascorbate 400mg capsules | — | 0001 | NHS dm+d VMP | ||
| United States | Sodium Ascorbate | Spectrum Laboratory Products, Inc. | Powder | FDA NDC | ||
| United States | Sodium Ascorbate | CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd | Powder | FDA NDC | ||
| United States | Sodium Ascorbate | DSM Nutritional Products, LLC | Powder | FDA NDC | ||
| United States | Sodium Ascorbate | DSM Nutritional Products LLC | Powder | FDA NDC |
See every manufacturer of Sodium Ascorbate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Sodium Ascorbate Inj 250mg/mL (DIN 00611867) marketed in Canada?
No. Health Canada lists DIN 00611867 as Dormant as of 02 Oct 2020.
Who holds the Canadian licence for this product?
Dominion Veterinary Laboratories Ltd. is the company of record in the Health Canada Drug Product Database.
Is Sodium Ascorbate registered outside Canada?
Yes — Nexara Health has matched 23 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00611867, status date 2020-10-02; national medicine registries: FDA NDC, NHS dm+d VMP, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00611867, status date 2020-10-02; national medicine registries: FDA NDC, NHS dm+d VMP, TFDA.
Health Canada Drug Product Database (DPD), DIN 00611867, status date 2020-10-02; national medicine registries: FDA NDC, NHS dm+d VMP, TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.